Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

2.63
Delayed Data
As of Dec 02
 -0.02 / -0.75%
Today’s Change
2.55
Today|||52-Week Range
4.74
-34.41%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close2.65
Today’s open2.67
Day’s range2.62 - 2.70
Volume145,892
Average volume (3 months)164,813
Market cap$112.0M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-853.85%
Earnings growth (this year)-3.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.90%
P/E ratioNM
Price/Sales2,402.53
Price/Book0.65

Competitors

 Today’s
change
Today’s
% change
NEOSNeos Therapeutics In...+0.50+7.19%
NAVBNavidea Biopharmaceu...-0.01-1.81%
FLKSFlex Pharma Inc-0.01-0.16%
CORICorium International...+0.32+6.30%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$70.0K
Annual profit (last year)-$41.3M
Net profit margin-58,956.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Michael A. Sherman
Director &
Chief Science Officer
Philip S. Low
Corporate headquarters
West Lafayette, Indiana

Forecasts


Search for Jobs